Yes, concur with that Footnort. Leslie emphasised that it is very important that the FDA have confidence that the company being granted the breakthrough designation will deliver the program and allocate the resources sufficient to maximise that chances of success. She said this in response to my question re the possibility of making a number of BD applications at the one time.
Ann: Imugene Corporate Presentation, page-230
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $440.9M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.2¢ | 5.7¢ | $1.375M | 22.89M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 1889589 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 838797 | 23 |
View Market Depth
| Last trade - 12.31pm 15/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |